Use of NK-1 receptor antagonists for treating sexual dysfunctions
US5929054A · kind A · utility
21Cited by
7References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 1, 1997 |
| Grant date | Jul 27, 1999 |
| Priority date | — |
| Expiry date | Dec 1, 2017 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method for the treatment or prevention of sexual dysfunctions which comprises oral administration of an orally active, long acting, CNS-penetrant NK-1 receptor antagonist and pharmaceutical compositions comprising such an NK-1 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.